Biora Therapeutics, Inc.
BIORQ
$0.1174
-$0.0086-6.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.13M | -71.18M | -95.45M | -108.70M | -122.42M |
| Total Depreciation and Amortization | 326.00K | 340.00K | 396.00K | 438.00K | 596.00K |
| Total Amortization of Deferred Charges | 3.22M | 2.65M | 2.69M | 1.13M | 1.49M |
| Total Other Non-Cash Items | -32.37M | 25.30M | 48.74M | 62.97M | 62.52M |
| Change in Net Operating Assets | 12.78M | 8.41M | 8.47M | 9.42M | 12.04M |
| Cash from Operations | -32.18M | -34.48M | -35.15M | -34.75M | -45.77M |
| Capital Expenditure | -214.00K | -196.00K | -36.00K | -37.00K | -109.00K |
| Sale of Property, Plant, and Equipment | 20.00K | 20.00K | 21.00K | 11.00K | 11.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.00M | 3.00M | 3.00M | -- | -- |
| Cash from Investing | 2.81M | 2.82M | 2.99M | -26.00K | -98.00K |
| Total Debt Issued | 10.81M | 2.81M | 2.81M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 6.47M | 6.28M | 2.98M | 13.06M | 15.63M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.00K | -1.21M | 4.09M | 3.80M | 5.75M |
| Cash from Financing | 17.36M | 7.89M | 9.88M | 16.86M | 21.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.02M | -23.77M | -22.29M | -17.92M | -24.49M |
